COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization

被引：23

作者：

Korompoki, Eleni ^{[1
]}

Gavriatopoulou, Maria ^{[1
]}

Kontoyiannis, Dimitrios P. ^{[2
]}

机构：

[1] Natl & Kapodistrian Univ Athens, Sch Med, Dept Clin Therapeut, Athens, Greece

[2] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, 1515 Holcombe Blvd,Unit 1460, Houston, TX 77030 USA

来源：

JAMA ONCOLOGY | 2021年 / 7卷 / 08期

关键词：

D O I：

10.1001/jamaoncol.2021.1218

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1113 / 1114

页数：2

共 9 条

[1]

American Society of Clinical Oncology, NEWS ANAL

[2] Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? [J].

Chamilos, Georgios ;

Lionakis, Michail S. ;

Kontoyiannis, Dimitrios P. .

CLINICAL INFECTIOUS DISEASES, 2021, 72 (02) :351-356

[3] Reinfection With SARS-CoV-2: Implications for Vaccines [J].

Cohen, Jeffrey, I ;

Burbelo, Peter D. .

CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) :E4223-E4228

[4] Commentary: SARS-CoV-2 vaccines and cancer patients [J].

Corti, C. ;

Curigliano, G. .

ANNALS OF ONCOLOGY, 2021, 32 (04) :569-+

[5] COVID-19 vaccine race: watch your step for cancer patients [J].

Fanciullino, Raphaelle ;

Ciccolini, Joseph ;

Milano, Gerard .

BRITISH JOURNAL OF CANCER, 2021, 124 (05) :860-861

[6] The dangers of DNA vaccination [J].

Górecki, DC ;

Simons, JP .

NATURE MEDICINE, 1999, 5 (02) :126-126

[7] Cell-Mediated Immunogenicity of Influenza Vaccination in Patients With Cancer Receiving Immune Checkpoint Inhibitors [J].

Kang, Chang Kyung ;

Kim, Hang-Rae ;

Song, Kyoung-Ho ;

Keam, Bhumsuk ;

Choi, Seong Jin ;

Choe, Pyoeng Gyun ;

Kim, Eu Suk ;

Kim, Nam Joong ;

Kim, Yu Jung ;

Park, Wan Beom ;

Kim, Hong Bin ;

Oh, Myoung-don .

JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (11) :1902-1909

[8] Approaches for Optimal Use of Different COVID-19 Vaccines Issues of Viral Variants and Vaccine Efficacy [J].

Moore, John P. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (13) :1251-1252

[9]

UK Government, 2020, GUID SHIELD PROT PEO

← 1 →